<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092017000200078</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[La variabilidad de la glucemia en pacientes críticamente enfermos: el manejo deberá ser personalizado]]></article-title>
<article-title xml:lang="en"><![CDATA[Glycemic variability in critically ill patients: the management should be customized]]></article-title>
<article-title xml:lang="pt"><![CDATA[A variabilidade glicêmica em pacientes em estado crítico: o tratamento deve ser personalizado]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cruz Gómez]]></surname>
<given-names><![CDATA[Lida Montserrat]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Guillén]]></surname>
<given-names><![CDATA[Job Heriberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Monares Zepeda]]></surname>
<given-names><![CDATA[Enrique]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Galindo Martín]]></surname>
<given-names><![CDATA[Carlos Alfredo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Galavis]]></surname>
<given-names><![CDATA[Brenda Silvana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aportela Vázquez]]></surname>
<given-names><![CDATA[Verónica Angélica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital San Ángel Inn Universidad  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2017</year>
</pub-date>
<volume>31</volume>
<numero>2</numero>
<fpage>78</fpage>
<lpage>83</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092017000200078&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092017000200078&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092017000200078&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  Los tres dominios del control glucémico (hipoglucemia, hiperglucemia y variabilidad glucémica) componen un marco conceptual para la disminución de los riesgos asociados a él durante la enfermedad crítica. Aun así, el componente premórbido no suele ser tomado en cuenta en dichos dominios. Se ha demostrado que las metas de glucosa en sangre más liberales pueden beneficiar a aquellos pacientes con hiperglucemia crónica, contrariamente a lo que se ha demostrado en individuos con buen manejo glucémico premórbido.  Material y métodos:  Mediante el uso de las cifras de hemoglobina glucosilada (HbA1c) y la glucosa predicha de 90 días previos se desarrolló una fórmula de «variabilidad glucémica relativa» (VGR) en sujetos adultos críticamente enfermos. Luego, mediante los valores de glucosa capilar, se obtuvieron los eventos de hipoglucemia, la media de glucemia capilar, VGR y coeficiente de variación (CV) glucémica durante los primeros siete días de estancia. Se dividió a la población en HbA1c &lt; 7% y &#8805; 7%, así como en vivos y muertos, y se compararon las variables capturadas y calculadas entre estos.  Resultados:  Mediante el protocolo de control glucémico, las personas con HbA1c &#8805; 7% mantuvieron una VGR negativa; es decir, cifras menores a lo habituado. En el grupo &lt; 7%, permanecieron positivas; es decir, mayores a lo habitual. El primer grupo mostró una estancia hospitalaria mayor, nueve versus siete días (p &lt; 0.05); aquellos pacientes con HbA1c &lt; 7% fallecidos mostraron un CV mayor (p &lt; 0.05) 27.49 (11.02-37.07) versus 12.49 (8.2-8.75). Dicha asociación no se encontró en el grupo &#8805; 7%.  Conclusión:  La VGR negativa en relación con el control premórbido muestra efectos negativos en la evolución de los individuos con mal manejo glucémico previo. A su vez, un CV de mayor magnitud mostró su efecto negativo en la mortalidad de aquellos sujetos con buena regulación anterior. Se reitera que en relación con el control glucémico, efectivamente «una talla no se ajusta a todos».]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  The three domains of glycemic control (hypoglycemia, hyperglycemia and glycemic variability) comprise a conceptual framework for reducing the risk associated with it during critical illness. However, the premorbid component is usually not taken into account. It has been shown that those patients with chronic hyperglycemia could benefit from more liberal glycemic goals, contrary to what has been shown in patients with good premorbid glycemic control.  Material and methods:  By using the glycosylated hemoglobin (HbA1c) and predicted glucose of the previous 90 days, a formula of «relative glycemic variability» (RGV) in critically ill adult patients was developed. Then, using the capillary glucose values, events of hypoglycemia were obtained, as well as mean capillary glucose, RGV and coefficient of variation (CV) during the first seven days of stay. The population was divided into HbA1c &lt; 7% and &#8805; 7%, as well as in alive and deceased; the variables between them captured and calculated were compared.  Results:  Using the glycemic control protocol, HbA1c &#8805; 7% patients maintained a negative RGV, that is, lower values than usual; the group &lt; 7% kept a positive RV, higher than usual. The first group showed a prolonged hospital stay, nine versus seven days (p &lt; 0.05), and those deceased and with HbA1c &lt; 7% showed a higher CV (p &lt; 0.05), 27.49 (11.02-37.07) versus 12.49 (8.2-8.75); such association was not observed in the group of patients &#8805; 7%.  Conclusion:  Negative RGV in relation to premorbid control shows negative effects on the evolution of patients with poor previous glycemic control; at the same time, a greater CV showed its negative effect in patients with good previous control. It is reasserted that, in relation to glycemic control, «one size does not fit all».]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  Os três domínios do controle glicêmico (hipoglicemia, hiperglicemia e variabilidade glicêmica) compreendem uma estrutura conceitual para reduzir os riscos associados com tais controles durante a doença crítica. No entanto, o componente pré-mórbido geralmente não acostuma ser tomado em conta neste âmbito. Demonstrou-se que em pacientes com hiperglicemia crônica as metas da glicemia no sangue mais flexíveis podem beneficiar essa população, ao contrário do que tem sido demonstrado em pacientes com um adequado controle glicêmico pré-mórbido.  Material e metodos:  Utilizando as cifras da hemoglobina glicosilada (HbA1c) e a glicemia prevista de 90 dias prévios, desenvolveu-se uma fórmula da «Variabilidade Glicêmica Relativa» (VGR) nos pacientes adultos em estado crítico. Posteriormente, por meio de valores da glicemia capilar foram obtidos os episódios de hipoglicemia, glicemia capilar média, VGR e coeficiente de variabilidade glicêmica (CV) durante os primeiros 7 dias de estadia hospitalar. A população foi dividida em HbA1c &lt; 7% e &#8805;7%, assim como nos vivos e mortos, comparando as variáveis &#8203;&#8203;capturadas e calculadas entre elas.  Resultados:  Utilizando o protocolo de controle glicêmico, os pacientes HbA1c &#8805;7 mantiveram uma VGR negativa, isto é, cifras menores que a habitual e no grupo &lt; 7% positivas que é maior do que o habitual. O primeiro grupo mostrou uma estadia hospitalar maior a 9 vs 7 dias (p &lt; 0.05) e os pacientes com HbA1c &lt; 7% falecidos mostraram um CV maior (p &lt; 0.05) 27.49 (11.02-37.07) vs 12.49 (8.2-8.75), tal associação não foi encontrada no grupo &#8805;7%.  Conclusão:  A VGR negativa em relação ao controle pré-mórbido mostra efeitos negativos na evolução dos pacientes com um inadecuado controle glicêmico, um CV de maior magnitude mostrou o seu efeito negativo na mortalidade em pacientes com um adequado controle prévio. Reitera-se que, em relação ao controle glicêmico, efetivamente «uma medida não serve para todos».]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Variabilidad glucémica]]></kwd>
<kwd lng="es"><![CDATA[control glucémico]]></kwd>
<kwd lng="es"><![CDATA[paciente crítico]]></kwd>
<kwd lng="en"><![CDATA[Glycemic variability]]></kwd>
<kwd lng="en"><![CDATA[glycemic control]]></kwd>
<kwd lng="en"><![CDATA[critically ill patient]]></kwd>
<kwd lng="pt"><![CDATA[Varibilidade glicêmica]]></kwd>
<kwd lng="pt"><![CDATA[controle glicêmico]]></kwd>
<kwd lng="pt"><![CDATA[paciente em estado crítico]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Honiden]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Inzcchi]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic management during critical illness glycemic control in the ICU]]></article-title>
<source><![CDATA[Semin Respir Crit Care Med]]></source>
<year>2015</year>
<volume>36</volume>
<page-range>859-69</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Hooijdonk]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Mesotten]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Krinsley]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Schultz]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sweet spot glucose control in the intensive care unit]]></article-title>
<source><![CDATA[Semin Respir Crit Care Med]]></source>
<year>2016</year>
<volume>37</volume>
<page-range>57-67</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clain]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ramar]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Surani]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glucose control in critical care]]></article-title>
<source><![CDATA[World J Diabetes]]></source>
<year>2015</year>
<volume>6</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1082-91</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Krinsley]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glycemic control in the critically ill what have we learned since nice-sugar?]]></article-title>
<source><![CDATA[Hosp Pract (1995)]]></source>
<year>2015</year>
<volume>43</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>191-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meyfroidt]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Blood glucose amplitude variability in critically ill patients]]></article-title>
<source><![CDATA[Minerva Anestesiol]]></source>
<year>2015</year>
<volume>81</volume>
<page-range>1010-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baithwaite]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glycemic variability in hospitalized patients choosing metrics while awaiting evidence]]></article-title>
<source><![CDATA[Curr Diab Rep]]></source>
<year>2013</year>
<volume>13</volume>
<page-range>138-54</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nathan]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Kuenen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Borg]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Schoenfeld]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Heine]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Translating the A1C assay into estimated average glucose values]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2008</year>
<volume>31</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1473-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donati]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Damiani]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Domizi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Botticelli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Castagnani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gabbanelli]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glycaemic variability, infections and mortality in a medical-surgical intensive care unit]]></article-title>
<source><![CDATA[Crit Care Resusc]]></source>
<year>2014</year>
<volume>16</volume>
<page-range>13-23</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Krinsley]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Egi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kiss]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Devendra]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Schuetz]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Maurer]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients an international multicenter cohort study]]></article-title>
<source><![CDATA[Critical Care]]></source>
<year>2013</year>
<volume>17</volume>
<page-range>R37</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
